A THERAPEUTIC AND DIAGNOSTIC TARGET GENE IN ACUTE MYELOID LEUKEMIA

World Intellectual Property Organization Patent

APP PUB NO WO-2012151390-A2
SERIAL NO

PCTUS2012036303

Stats

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods are provided for treating a cancer in a subject comprising administering to the subject an agent which inhibits expression of an HLX gene in the subject, or an agent which inhibits activity of an expression product of the HLX gene, and also for diagnosing a subject as likely to develop a cancer comprising determining whether a stem cell obtained from the subject expresses a HLX gene at a level in excess of predetermined control level. Kits therefor are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • Owner owned or assignment not recorded

International Classification(s)

Inventor(s)

  • No Inventor to display

Cited Art Landscape

Load Citation